Product Images Glipizideer ER

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 3 images provide visual information about the product associated with Glipizideer ER NDC 33261-835 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

structural formula for Glipizide - glipizide er 5mg 10mg tab for patheon 1

structural formula for Glipizide - glipizide er 5mg 10mg tab for patheon 1

IMAGE LABEL - glipizide er 5mg 10mg tab for patheon 2

IMAGE LABEL - glipizide er 5mg 10mg tab for patheon 2

This is a description of a medication named Glipizide, an extended-release tablet that comes in a bottle of 30 tablets. The tablets are 5mg and are orange in colour, with the NDC number 33261-0830-30. The medication is manufactured by AIDAREX PHARMACEUTICALS LLC under the brand name "Supzideering" and is a generic for "Glucotrol XL RX QLS0000". The tablets are to be taken orally, with a dosage of one tablet every 24 hours. The manufacturing company is Patheon Pharmaceuticals Inc. based in Cincinnati, Ohio.*

IMAGE LABEL - glipizide er 5mg 10mg tab for patheon 3

IMAGE LABEL - glipizide er 5mg 10mg tab for patheon 3

This is a description of a medication called "Gupizideer 10mg" manufactured by AIDAREX PHARMACEUTICALS LLC. The medication comes in a white, round tablet form and is taken orally. Each bottle contains 30 tablets with an extended release formula. The active ingredient is 10mg of Gupizide, which is a generic for GlucotrolX. The National Drug Code (NDC) for this medication is 33261-0835-30.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.